Latif
Latif Kazim, Amherst, NY US
Patent application number | Description | Published |
---|---|---|
20080293103 | STRESS PROTEIN COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CANCER AND INFECTIOUS DISEASE - Pharmaceutical compositions comprising a stress protein complex and related molecules encoding or cells presenting such a complex are provided. The stress protein complex comprises an hsp110 or grp170 polypeptide complexed with an immunogenic polypeptide. The immunogenic polypeptide of the stress protein complex can be associated with a cancer or an infectious disease. Preferred immunogenic polypeptides include gp100, her2/neu ECD-PD, ICD and | 11-27-2008 |
Latif Mahjoob, Paramount, CA US
Patent application number | Description | Published |
---|---|---|
20100018116 | SYSTEM AND METHOD FOR CONVERTING SOLIDS INTO FUEL - A system for converting a solid fuel into a fuel including a pyrolytic unit for producing a pyro gas comprising hydrocarbons, a synthesis gas production unit for converting the pyro gas into a synthesis gas comprising a mixture of hydrogen and carbon monoxide, and a gas-to-liquid unit for converting the synthesis gas into a fuel. | 01-28-2010 |
Latif Tezduyar, Istanbul TR
Patent application number | Description | Published |
---|---|---|
20110118895 | Household Appliance - The present invention relates to a household appliance ( | 05-19-2011 |
20110167879 | Washing Machine - The present invention relates to a washing machine ( | 07-14-2011 |
Latif Wafa, Burnaby CA
Patent application number | Description | Published |
---|---|---|
20100048709 | Treatment of Prostate Cancer with DDC Inhibitor - Prostate cancer comes in various forms and has proven difficult to treat. Provided herein are various methods and compositions for treating all forms of prostate cancers with dopa decarboxylase (DDC) inhibitors. These dopa decarboxylase inhibitors include carbidopa (α-Methyl-dopahydrazine), MFMD (α-monofluoromethyldopa), NSD-1015 (3-hydroxybenzylhydrazine), Methyldopa (L-α-Methyl-3,4-dihydroxyphenylalanine) or benserazide, and the inhibitors may be used in combination. DDC inhibitors may also be used to inhibit the progression of prostate cancer to androgen-independence and neuroendocrine prostate cancer. | 02-25-2010 |